Notes
Camurus AB provided funds for the study.
Reference
Wright N, et al. OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis. ClinicoEconomics and Outcomes Research : 9 Sep 2020. Available from: URL: https://doi.org/10.2147/CEOR.S256714
Rights and permissions
About this article
Cite this article
Prolonged-release buprenorphine for OUD in prisons reduces costs. PharmacoEcon Outcomes News 862, 24 (2020). https://doi.org/10.1007/s40274-020-7142-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7142-5